AIMT - Aimmune Therapeutics' (AIMT) CEO Jayson Dallas on Q4 2018 Results - Earnings Call Transcript
Aimmune Therapeutics, Inc. (AIMT)
Q4 2018 Earnings Conference Call
February 28, 2019 5:00 PM ET
Company Participants
Laura Hansen — Vice President of Investor Relations
Jayson Dallas — President and Chief Executive Officer
Daniel Adelman — Chief Medical Officer
Andrew Oxtoby — Chief Commercial Officer
Eric Bjerkholt — Chief Financial Officer
Conference Call Participants
Chris Raymond — Piper Jaffray
Charles Duncan — Cantor Fitzgerald
Aspen Mori — Bank of America Merrill Lynch
Kennen MacKay — RBC Capital Markets
Liana Moussatos — Wedbush Securities
Vamil Divan — Credit Suisse
Liisa Bayko — JMP Securities
Paul Choi